VivoSeq
Hematology

Bone Marrow Failure

0

Pipeline Programs↗

4

Active Trials↗

0

Companies Involved↗

Bone Marrow Failure is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

0/100

Attrition Rate

17/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Recruiting2 · 33%
Not yet recruiting2 · 33%
Unknown status1 · 17%
Terminated1 · 17%

Clinical Trials

Trial Activity

6 trials

Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
Recruiting·SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins·Phase 2·NCT04232085·27 enrolled
Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease
Recruiting·—·N/A·NCT05823376·40 enrolled
REscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2
Not yet recruiting·MMelbourne Health·Phase 1/2·NCT06607367·20 enrolled
A Phase II Prospective Study Evaluating Selective Depletion of CD45RA+ (Naïve) T Cells (TND) From Peripheral Blood Stem Cell (PBSC) Grafts for Prevention of Graft Versus Host Disease (GVHD) in Non-Malignant Diseases (NMDs)
Not yet recruiting·FFred Hutchinson Cancer Center·Phase 2·NCT07660783·40 enrolled
A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
Terminated·National Heart, Lung, and Blood Institute (NHLBI)·Phase 2·NCT00001962·100 enrolled
MNCs for Bone Marrow Failure After Malignant Diseases Children Chemotherapy
Unknown status·QQianfoshan Hospital·N/A·NCT05628272·20 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)